Paxil CR paroxetine tablets recalled for dissolution test failure
Apotex Corp. is recalling one lot of Paxil CR (paroxetine) 37.5mg extended-release tablets because the medication failed to meet dissolution specifications during 24-month stability testing. This means the tablets may not release the drug into the body as intended. The affected lot (TY9494, expiration 05/31/2027) was distributed nationwide.
From the FDA notice · Read the official notice ↗ · All Apotex recalls
What to do
- Check your Paxil CR bottle for lot number TY9494 with expiration date 05/31/2027.
- If you have this lot, contact your pharmacy or prescriber before stopping the medication.
- Do not stop taking paroxetine abruptly without medical guidance.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 6,972 bottles
- Illnesses reported
- None reported
- Manufactured in
- 2400 N Commerce Pkwy Ste 400, N/A, Weston, FL, United States
- Classification
- Class II
- Recall number
- D-0804-2026
In the FDA's words
- Description
- Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-4379-3 Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria Lot # TY9494, Exp Date: 05/31/2027. Distribution: US Nationwide. Affected quantity: 6,972 bottles
- Hazard
- Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria
More from Apotex
See all- Apotex paroxetine ER tablets recalled for failed dissolution
ModerateFDAOct 7, 2026